Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-13 Quart Barry D Chief Executive Officer Option exercise · Restricted Stock Units −3,645 25,521
2023-01-13 Quart Barry D Chief Executive Officer Option exercise · Restricted Stock Units −16,122 114,807
2023-01-13 POYHONEN JOHN President & CCO Option exercise +1,250 40,294
2023-01-13 POYHONEN JOHN President & CCO Option exercise +4,564 44,858
2023-01-13 POYHONEN JOHN President & CCO Shares withheld for taxes −2,012 $3.17 $6K 42,846
2023-01-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −1,250 8,750
2023-01-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −4,564 32,500
2023-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +552 21,141
2023-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +1,933 23,074
2023-01-13 Peraza Lisa VP, Chief Accounting Officer Shares withheld for taxes −1,013 $3.17 $3K 22,061
2023-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −552 3,864
2023-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −1,933 13,761
2023-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +1,250 21,381
2023-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +4,564 25,945
2023-01-13 MANHARD KIMBERLY EVP, Drug Development Shares withheld for taxes −2,012 $3.17 $6K 23,933
2023-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −1,250 8,750
2023-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −4,564 32,500
2022-12-16 Christian Waage Director Grant or award +38,580 52,232
2022-12-16 Christian Waage Director Grant or award · Stock Option (Right to Buy) +77,160 77,160
2022-12-16 Rodriguez Susan Director Grant or award +38,580 55,282

Page 17 of 28 · 557 trades